Neurodegenerative Tauopathies

Article Properties
  • Language
    English
  • Publication Date
    2001/03/01
  • Indian UGC (Journal)
  • Refrences
    256
  • Citations
    1,775
  • Virginia M-Y Lee Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104;Medical Research Council, Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, United Kingdom;
  • Michel Goedert Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104;Medical Research Council, Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, United Kingdom;
  • John Q Trojanowski Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104;Medical Research Council, Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, United Kingdom;
Abstract
Cite
Lee, Virginia M-Y, et al. “Neurodegenerative Tauopathies”. Annual Review of Neuroscience, vol. 24, no. 1, 2001, pp. 1121-59, https://doi.org/10.1146/annurev.neuro.24.1.1121.
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001). Neurodegenerative Tauopathies. Annual Review of Neuroscience, 24(1), 1121-1159. https://doi.org/10.1146/annurev.neuro.24.1.1121
Lee VMY, Goedert M, Trojanowski JQ. Neurodegenerative Tauopathies. Annual Review of Neuroscience. 2001;24(1):1121-59.
Journal Categories
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Description

Can understanding the molecular basis of tauopathies unlock new therapies for Alzheimer's disease? This comprehensive review delves into the intricate relationship between tau protein abnormalities and neurodegenerative disorders, highlighting recent advancements in understanding the etiology and pathogenesis of these devastating conditions. The paper explores the defining neuropathological characteristics of Alzheimer's disease, including the presence of filamentous tau lesions and fibrillar amyloid β peptides. Furthermore, it examines neurodegenerative tauopathies such as corticobasal degeneration, progressive supranuclear palsy, and Pick's disease, as well as hereditary frontotemporal dementia. Multiple tau gene mutations are identified as pathogenic factors, with tau polymorphisms acting as genetic risk indicators for sporadic progressive supranuclear palsy and corticobasal degeneration. Emerging data supports the hypothesis that different tau gene mutations impair tau functions, promote tau fibrillization, or disrupt tau gene splicing, thereby leading to the formation of biochemically and structurally distinct tau aggregates. The study emphasizes the need to test hypothetical mechanisms through transgenic models to accelerate the discovery of more effective therapies for neurodegenerative tauopathies and related disorders, including Alzheimer's disease. While diverse FTDP-17 syndromes exist, influenced by genetic or epigenetic factors, the insights gained from transgenic models promise to unveil more effective therapies for neurodegenerative tauopathies, including Alzheimer's disease, by targeting the pathogenic mechanisms of tau abnormalities.

Published in the Annual Review of Neuroscience, this paper aligns with the journal's focus on providing comprehensive reviews of significant advances in the field. By examining the molecular underpinnings of neurodegenerative diseases, specifically the role of tau protein, the paper contributes to the journal's exploration of brain function and dysfunction. Its extensive citation of related works in neuroscience underscores its relevance to the journal's readership and its contribution to the ongoing scientific dialogue.

Refrences
Citations
Citations Analysis
The first research to cite this article was titled Update on the Neuropathological Diagnosis of Frontotemporal Dementias and was published in 2001. The most recent citation comes from a 2024 study titled Update on the Neuropathological Diagnosis of Frontotemporal Dementias . This article reached its peak citation in 2022 , with 104 citations.It has been cited in 536 different journals, 22% of which are open access. Among related journals, the Journal of Biological Chemistry cited this research the most, with 88 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year